Utama › Penyakit Kardiovaskular › Ohio › Cincinnati
Kajian klinikal Penyakit Kardiovaskular di Cincinnati, OH
16 kajian untuk Penyakit Kardiovaskular sedang mencari peserta di lokasi dalam dan sekitar Cincinnati (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Mengambil pesertaFasa 2
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Mengambil pesertaFasa 3
- The Christ Hospital, Cincinnati
- Velocity Clinical Research-Cincinnati-69044, Cincinnati
Product Surveillance Registry
Mengambil pesertaKajian pemerhatian
- Edgewood, Edgewood · 8 mi jauh
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Mengambil pesertaFasa 3
- Clinical Trial Site, Cincinnati
- Clinical Trial Site, Cincinnati
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mengambil peserta
- The Christ Hospital, Cincinnati
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Mengambil peserta
- The Christ Hospital - Cincinnati, Cincinnati
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
- Cincinnati VA Medical Center, Cincinnati
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Mengambil pesertaKajian pemerhatian
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Mengambil pesertaFasa 3
- Research Site, Cincinnati
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Mengambil pesertaFasa 3
- The Christ Hospital, Cincinnati
- Velocity Clinical Research - Cincinnati, Cincinnati
The TRICURE EFS Study
Mengambil peserta
- The Christ Hospital, Cincinnati
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Mengambil peserta
- The Christ Hospital- Cincinnati, Cincinnati
- University of Cincinnati, Cincinnati
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Mengambil peserta
- Christ Hospital, Cincinnati
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Mengambil peserta
- Lindner Research Center at the Christ Hospital, Cincinnati
Heart Institute BioRepository (HIBR) for Pediatric Heart Disease
Mengambil pesertaKajian pemerhatian
- Children's Hospital Medical Center, Cincinnati, Cincinnati
PARTNER 3 Trial - Aortic Valve-in-Valve
Mengambil peserta
- The Christ Hospital, Cincinnati
Kajian Penyakit Kardiovaskular di bandar lain
- Boston, MA37 kajian
- New York City, NY33 kajian
- Washington, DC29 kajian
- Houston, TX24 kajian
- Dallas, TX23 kajian
- Atlanta, GA22 kajian
- Cleveland, OH22 kajian
- Chicago, IL21 kajian
- Philadelphia, PA21 kajian
- Pittsburgh, PA20 kajian
- St. Louis, MO20 kajian
- San Francisco, CA18 kajian
Kajian lain di Cincinnati
- Kanser Paru-paru Bukan Sel Kecil35 kajian
- Kanser (semua jenis)27 kajian
- Kanser Payudara25 kajian
- Kegagalan Jantung24 kajian
- Kanser Kolorektal21 kajian
- Leukemia Mieloid Akut20 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari19 kajian
- Kanser Paru-paru19 kajian
- Obesiti19 kajian
- Kanser Prostat18 kajian
- Mieloma Pelbagai17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.